Dr Michelle Perugini

Co-Founder @ Presagen

Dr Michelle Perugini is an academic, entrepreneur, and an internationally renowned expert in health, medical research, advanced analytics, and cognitive AI.

Michelle spent the first 13 years of her career in health and medical research, specializing in predictive genetics and translational medicine. She was the pioneer of new methods in proteomics that now drive drug discovery.

Michelle co-founded global technology company ISD Analytics, with award-winning predictive analytics product Simulait, which was acquired by Ernst and Young (EY) in 2015.

Michelle has authored various research papers and is the recipient of many innovation awards and grants. Michelle now mentors and is the co-founder of various tech start-ups.